Philip E. Castle

6.4k total citations
108 papers, 4.3k citations indexed

About

Philip E. Castle is a scholar working on Epidemiology, Surgery and Oncology. According to data from OpenAlex, Philip E. Castle has authored 108 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Epidemiology, 35 papers in Surgery and 33 papers in Oncology. Recurrent topics in Philip E. Castle's work include Cervical Cancer and HPV Research (78 papers), Genital Health and Disease (33 papers) and Hepatitis B Virus Studies (23 papers). Philip E. Castle is often cited by papers focused on Cervical Cancer and HPV Research (78 papers), Genital Health and Disease (33 papers) and Hepatitis B Virus Studies (23 papers). Philip E. Castle collaborates with scholars based in United States, Rwanda and United Kingdom. Philip E. Castle's co-authors include Mark Schiffman, Diane Solomon, Mark E. Sherman, Vikrant V. Sahasrabuddhe, Attila T. Lörincz, Cosette M. Wheeler, Sholom Wacholder, Allan Hildesheim, José Jerónimo and Walter Kinney and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Philip E. Castle

107 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip E. Castle United States 37 3.3k 1.5k 1.1k 782 532 108 4.3k
Fanghui Zhao China 34 4.2k 1.3× 1.4k 0.9× 1.6k 1.4× 847 1.1× 715 1.3× 246 5.2k
Clare Gilham United Kingdom 24 3.1k 0.9× 1.3k 0.9× 1.3k 1.1× 570 0.7× 505 0.9× 48 4.1k
Laia Alemany Spain 33 3.3k 1.0× 1.8k 1.2× 1.1k 1.0× 625 0.8× 294 0.6× 96 4.7k
Jorge Morales United States 29 3.8k 1.1× 1.9k 1.3× 714 0.6× 628 0.8× 739 1.4× 74 4.4k
Anne Szarewski United Kingdom 33 4.0k 1.2× 1.5k 1.0× 1.3k 1.1× 794 1.0× 715 1.3× 82 4.6k
Mark Schiffman United States 26 4.1k 1.3× 1.8k 1.2× 1.2k 1.1× 584 0.7× 665 1.3× 42 4.7k
Gloria Y. F. Ho United States 33 2.3k 0.7× 963 0.6× 922 0.8× 728 0.9× 364 0.7× 67 3.9k
Nubia Muñóz Spain 25 4.5k 1.4× 2.9k 1.9× 788 0.7× 555 0.7× 619 1.2× 52 5.7k
Martha L. Hutchinson United States 33 3.5k 1.1× 1.5k 1.0× 746 0.7× 557 0.7× 611 1.1× 69 4.2k
Christine Bergeron France 40 3.5k 1.1× 1.7k 1.1× 999 0.9× 651 0.8× 496 0.9× 99 5.1k

Countries citing papers authored by Philip E. Castle

Since Specialization
Citations

This map shows the geographic impact of Philip E. Castle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip E. Castle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip E. Castle more than expected).

Fields of papers citing papers by Philip E. Castle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip E. Castle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip E. Castle. The network helps show where Philip E. Castle may publish in the future.

Co-authorship network of co-authors of Philip E. Castle

This figure shows the co-authorship network connecting the top 25 collaborators of Philip E. Castle. A scholar is included among the top collaborators of Philip E. Castle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip E. Castle. Philip E. Castle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murenzi, Gad, Fidel Rubagumya, Jonathan Ross, et al.. (2025). Building health research capacity in Africa: the Einstein-Rwanda research and capacity building program. PubMed. 3(1). 16–16.
2.
Uusküla, Anneli, et al.. (2025). Prevention and control of HPV-related cancers in people living with HIV. The Lancet HIV. 12(4). e293–e302. 3 indexed citations
3.
Rubinstein, Wendy S., Christos Patriotis, Anthony Dickherber, et al.. (2024). Cancer screening with multicancer detection tests: A translational science review. CA A Cancer Journal for Clinicians. 74(4). 368–382. 34 indexed citations
4.
Dusingize, Jean Claude, Gad Murenzi, Eric Remera, et al.. (2024). Cancer risk among people living with Human Immunodeficiency Virus ( HIV) in Rwanda from 2007 to 2018. International Journal of Cancer. 155(12). 2149–2158. 2 indexed citations
5.
Stanton, Sasha E., Philip E. Castle, Olivera J. Finn, Shizuko Sei, & Leisha A. Emens. (2024). Advances and challenges in cancer immunoprevention and immune interception. Journal for ImmunoTherapy of Cancer. 12(3). e007815–e007815. 12 indexed citations
6.
Berg, Christine D., Philip E. Castle, David L. Crosby, et al.. (2024). Considerations for using potential surrogate endpoints in cancer screening trials. The Lancet Oncology. 25(5). e183–e192. 15 indexed citations
7.
Pinheiro, Maísa, Nicolas Wentzensen, Michael Dean, et al.. (2024). Somatic mutations in 3929 HPV positive cervical cells associated with infection outcome and HPV type. Nature Communications. 15(1). 7895–7895. 4 indexed citations
8.
Landy, Rebecca, David Baldwin, Paul F. Pinsky, et al.. (2023). Recalibration of a Deep Learning Model for Low-Dose Computed Tomographic Images to Inform Lung Cancer Screening Intervals. JAMA Network Open. 6(3). e233273–e233273. 9 indexed citations
9.
Jerónimo, José, Beatrice Vetter, Maurício Maza, et al.. (2023). Toward 70% cervical cancer screening coverage: Technical challenges and opportunities to increase access to human papillomavirus (HPV) testing. SHILAP Revista de lepidopterología. 3(8). e0001982–e0001982. 9 indexed citations
10.
Campbell, Suzanne Hetzel, Nathalie C. Støer, Philip E. Castle, et al.. (2022). Impact of the Mobile Game FightHPV on Cervical Cancer Screening Attendance: Retrospective Cohort Study. JMIR Serious Games. 10(4). e36197–e36197. 3 indexed citations
11.
Nygård, Mari, Birgit Engesæter, Philip E. Castle, et al.. (2022). Randomized Implementation of a Primary Human Papillomavirus Testing–based Cervical Cancer Screening Protocol for Women 34 to 69 Years in Norway. Cancer Epidemiology Biomarkers & Prevention. 31(9). 1812–1822. 15 indexed citations
12.
Simms, Kate T., Julia Steinberg, Michael Caruana, et al.. (2019). Impact of Scaled up Human Papillomavirus Vaccination and Cervical Screening and the Potential for Global Elimination of Cervical Cancer in 181 Countries, 2020–99: A Modelling Study. Obstetrical & Gynecological Survey. 74(6). 345–347. 16 indexed citations
13.
Adedimeji, Adebola, Jean d’Amour Sinayobye, Brenda Asiimwe‐Kateera, et al.. (2019). Social contexts as mediator of risk behaviors in Rwandan men who have sex with men (MSM): Implications for HIV and STI transmission. PLoS ONE. 14(1). e0211099–e0211099. 26 indexed citations
14.
Castle, Philip E. & Miriam Cremer. (2013). Human Papillomavirus Testing in Cervical Cancer Screening. Obstetrics and Gynecology Clinics of North America. 40(2). 377–390. 12 indexed citations
15.
Pierce, Mark C., Xun Zhang, Wen‐Hua Zhang, et al.. (2012). A Pilot Study of Low-Cost, High-Resolution Microendoscopy as a Tool for Identifying Women with Cervical Precancer. Cancer Prevention Research. 5(11). 1273–1279. 52 indexed citations
16.
Wheeler, Cosette M., William C. Hunt, Jack Cuzick, et al.. (2012). A population‐based study of human papillomavirus genotype prevalence in the United States: Baseline measures prior to mass human papillomavirus vaccination. International Journal of Cancer. 132(1). 198–207. 138 indexed citations
17.
Castle, Philip E., et al.. (2009). Impact of Improved Classification on the Association of Human Papillomavirus With Cervical Precancer. American Journal of Epidemiology. 171(2). 155–163. 24 indexed citations
18.
Zeitlin, Larry, Philip E. Castle, Kevin J. Whaley, Thomas R. Moench, & Richard A. Cone. (1998). Comparison of an anti-HSV-2 monoclonal IgG and its IgA switch variant for topical immunoprotection of the mouse vagina. Journal of Reproductive Immunology. 40(1). 93–101. 7 indexed citations
19.
Castle, Philip E., Timothy E. Hoen, Kevin J. Whaley, & Richard A. Cone. (1998). Contraceptive testing of vaginal agents in rabbits. Contraception. 58(1). 51–60. 30 indexed citations
20.
Castle, Philip E., Kevin J. Whaley, Timothy E. Hoen, Thomas R. Moench, & Richard A. Cone. (1997). Contraceptive Effect of Sperm-Agglutinating Monoclonal Antibodies in Rabbits1. Biology of Reproduction. 56(1). 153–159. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fanghui Zhao Breakdown of academic impact, for papers by Clare Gilham Breakdown of academic impact, for papers by Laia Alemany Breakdown of academic impact, for papers by Jorge Morales Breakdown of academic impact, for papers by Anne Szarewski Breakdown of academic impact, for papers by Mark Schiffman Breakdown of academic impact, for papers by Gloria Y. F. Ho Breakdown of academic impact, for papers by Nubia Muñóz Breakdown of academic impact, for papers by Martha L. Hutchinson Breakdown of academic impact, for papers by Christine Bergeron
Rankless by CCL
2026